{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:06:08Z","timestamp":1787889968898,"version":"build-2784847793"},"reference-count":148,"publisher":"Zhejiang University Press","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1631\/jzus.b2300159","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T05:01:49Z","timestamp":1720674109000},"page":"451-470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook","IRF-1 \u5728\u809d\u810f\u75be\u75c5\u8c03\u63a7\u4e2d\u7684\u5173\u952e\u4f5c\u7528: \u8fdb\u5c55\u4e0e\u5c55\u671b"],"prefix":"10.1631","volume":"25","author":[{"given":"Tao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3696-9158","authenticated-orcid":false,"given":"Jianjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2212-4539","authenticated-orcid":false,"given":"Zhongyang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"635","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"issue":"9","key":"749_CR1","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/nar\/30.9.2068","volume":"30","author":"FF Alcantara","year":"2002","unstructured":"Alcantara FF, Tang H, McLachlan A, 2002. Functional characterization of the interferon regulatory element in the enhancer 1 region of the hepatitis B virus genome. Nucleic Acids Res, 30(9):2068\u20132075. https:\/\/doi.org\/10.1093\/nar\/30.9.2068","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"749_CR2","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4149\/av_2020_313","volume":"64","author":"A Alhetheel","year":"2020","unstructured":"Alhetheel A, Albarrag A, Hakami A, et al., 2020. In the peripheral blood mononuclear cells (PBMCs) of HCV infected patients the expression of STAT1 and IRF-1 is downregulated while that of caspase-3 upregulated. Acta Virol, 64(3): 352\u2013358. https:\/\/doi.org\/10.4149\/av_2020_313","journal-title":"Acta Virol"},{"issue":"1","key":"749_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2011.12.027","volume":"319","author":"MJ Armstrong","year":"2012","unstructured":"Armstrong MJ, Stang MT, Liu Y, et al., 2012. Interferon regulatory factor 1 (IRF-1) induces p21WAF1\/CIP1 dependent cell cycle arrest and p21WAF1\/CIP1 independent modulation of survivin in cancer cells. Cancer Lett, 319(1):56\u201365. https:\/\/doi.org\/10.1016\/j.canlet.2011.12.027","journal-title":"Cancer Lett"},{"key":"749_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.trim.2018.10.001","volume":"51","author":"S Assadiasl","year":"2018","unstructured":"Assadiasl S, Shahi A, Salehi S, et al., 2018. Interferon regulatory factors: where to stand in transplantation. Transpl Immunol, 51:76\u201380. https:\/\/doi.org\/10.1016\/j.trim.2018.10.001","journal-title":"Transpl Immunol"},{"issue":"9","key":"749_CR5","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1128\/JVI.02449-10","volume":"85","author":"A Banerjee","year":"2011","unstructured":"Banerjee A, Mazumdar B, Meyer K, et al., 2011. Transcriptional repression of C4 complement by hepatitis C virus proteins. J Virol, 85(9):4157\u20134166. https:\/\/doi.org\/10.1128\/JVI.02449-10","journal-title":"J Virol"},{"issue":"2","key":"749_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/hep.22988","volume":"50","author":"H Bender","year":"2009","unstructured":"Bender H, Wiesinger MY, Nordhoff C, et al., 2009. Interleukin-27 displays interferon-y-like functions in human hepatoma cells and hepatocytes. Hepatology, 50(2):585\u2013591. https:\/\/doi.org\/10.1002\/hep.22988","journal-title":"Hepatology"},{"issue":"2","key":"749_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cmet.2019.11.013","volume":"31","author":"BS Cai","year":"2020","unstructured":"Cai BS, Dongiovanni P, Corey KE, et al., 2020. Macrophage MerTK promotes liver fibrosis in nonalcoholic steatohepatitis. Cell Metab, 31(2):406\u2013421.e7. https:\/\/doi.org\/10.1016\/j.cmet.2019.11.013","journal-title":"Cell Metab"},{"issue":"1","key":"749_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/hep.27037","volume":"60","author":"A Castellaneta","year":"2014","unstructured":"Castellaneta A, Yoshida O, Kimura S, et al., 2014. Plasmacytoid dendritic cell-derived IFN-\u03b1 promotes murine liver ischemia\/reperfusion injury by induction of hepatocyte IRF-1. Hepatology, 60(1):267\u2013277. https:\/\/doi.org\/10.1002\/hep.27037","journal-title":"Hepatology"},{"issue":"8","key":"749_CR9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/hepr.12810","volume":"47","author":"M Cavalli","year":"2017","unstructured":"Cavalli M, Pan G, Nord H, et al., 2017. Genetic prevention of hepatitis C virus-induced liver fibrosis by allele-specific downregulation of MERTK. Hepatol Res, 47(8):826\u2013830. https:\/\/doi.org\/10.1111\/hepr.12810","journal-title":"Hepatol Res"},{"issue":"2","key":"749_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3892\/ol.2012.1051","volume":"5","author":"FF Chen","year":"2013","unstructured":"Chen FF, Jiang G, Xu KR, et al., 2013. Function and mechanism by which interferon regulatory factor-1 inhibits on-cogenesis. Oncol Lett, 5(2):417\u2013423. https:\/\/doi.org\/10.3892\/ol.2012.1051","journal-title":"Oncol Lett"},{"issue":"2","key":"749_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41419-023-05639-w","volume":"14","author":"XY Chen","year":"2023","unstructured":"Chen XY, Cai Q, Liang RK, et al., 2023. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies. Cell Death Dis, 14(2): 105. https:\/\/doi.org\/10.1038\/s41419-023-05639-w","journal-title":"Cell Death Dis"},{"issue":"2","key":"749_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bcp.2014.06.026","volume":"91","author":"YF Chen","year":"2014","unstructured":"Chen YF, Wang SH, Chang SJ, et al., 2014. Zhankuic acid A as a novel JAK2 inhibitor for the treatment of concanavalin A-induced hepatitis. Biochem Pharmacol, 91(2):217\u2013230. https:\/\/doi.org\/10.1016\/j.bcp.2014.06.026","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"749_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jhep.2007.02.020","volume":"47","author":"YY Chen","year":"2007","unstructured":"Chen YY, Sun R, Jiang W, et al., 2007. Liver-specific HBsAg transgenic mice are over-sensitive to Poly(I:C)-induced liver injury in NK cell- and IFN-\u03b3-dependent manner. J Hepatol, 47(2): 183\u2013190. https:\/\/doi.org\/10.1016\/johep.2007.02.020","journal-title":"J Hepatol"},{"issue":"5","key":"749_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41419-018-0477-1","volume":"9","author":"LP Cheng","year":"2018","unstructured":"Cheng LP, Geng L, Dai BH, et al., 2018. Repression of let-7a cluster prevents adhesion of colorectal cancer cells by enforcing a mesenchymal phenotype in presence of liver inflammation. Cell Death Dis, 9(5):489. https:\/\/doi.org\/10.1038\/s41419-018-0477-1","journal-title":"Cell Death Dis"},{"issue":"9","key":"749_CR15","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1021\/np4004323","volume":"76","author":"HI Cho","year":"2013","unstructured":"Cho HI, Kim KM, Kwak JH, et al., 2013. Protective mechanism of anethole on hepatic ischemia\/reperfusion injury in mice. J Nat Prod, 76(9):1717\u20131723. https:\/\/doi.org\/10.1021\/np4004323","journal-title":"J Nat Prod"},{"key":"749_CR16","doi-asserted-by":"publisher","first-page":"e52237","DOI":"10.7554\/eLife.52237","volume":"9","author":"CC Colpitts","year":"2020","unstructured":"Colpitts CC, Ridewood S, Schneiderman B, et al., 2020. Hepatitis C virus exploits cyclophilin A to evade PKR. eLife, 9: e52237. https:\/\/doi.org\/10.7554\/eLife.52237","journal-title":"eLife"},{"issue":"4","key":"749_CR17","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/lt.20637","volume":"12","author":"SP Cordoba","year":"2006","unstructured":"Cordoba SP, Wang CM, Williams R, et al., 2006. Gene array analysis of a rat model of liver transplant tolerance identifies increased complement C3 and the STAT-1\/IRF-1 pathway during tolerance induction. Liver Transpl, 12(4): 636\u2013643. https:\/\/doi.org\/10.1002\/lt.20637","journal-title":"Liver Transpl"},{"key":"749_CR18","doi-asserted-by":"publisher","first-page":"100900","DOI":"10.1016\/j.neo.2023.100900","volume":"40","author":"X Cui","year":"2023","unstructured":"Cui X, Zhao HY, Wei S, et al., 2023. Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppressing IL-6 secretion from macrophages. Neoplasia, 40:100900. https:\/\/doi.org\/10.1016\/j.neo.2023.100900","journal-title":"Neoplasia"},{"issue":"1","key":"749_CR19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000491732","volume":"48","author":"ZL Cui","year":"2018","unstructured":"Cui ZL, Li SP, Liu ZR, et al., 2018. Interferon regulatory factor 1 activates autophagy to aggravate hepatic ischemia-reperfusion injury by increasing high mobility group box 1 release. Cell Physiol Biochem, 48(1):328\u201333 8. https:\/\/doi.org\/10.1159\/000491732","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"749_CR20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, et al., 2023. Global burden of liver disease: 2023 update. J Hepatol, 79(2):516\u2013537. https:\/\/doi.org\/10.1016\/jjhep.2023.03.017","journal-title":"J Hepatol"},{"issue":"3","key":"749_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/SHK.0b013e3181f6aab0","volume":"35","author":"R Dhupar","year":"2011","unstructured":"Dhupar R, Klune JR, Evankovich J, et al., 2011. Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemia-reperfusion injury. Shock, 35(3):293\u2013301. https:\/\/doi.org\/10.1097\/SHK.0b013e3181f6aab0","journal-title":"Shock"},{"issue":"2","key":"749_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bbrc.2020.01.034","volume":"524","author":"K Dong","year":"2020","unstructured":"Dong K, Du Q, Cui X, et al., 2020. MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down-regulates the expression of interferon regulatory factor-1. Biochem Biophys Res Commun, 524(2):273\u2013279. https:\/\/doi.org\/10.1016\/j.bbrc.2020.01.034","journal-title":"Biochem Biophys Res Commun"},{"key":"749_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s10020-020-00182-2","volume":"26","author":"Q Du","year":"2020","unstructured":"Du Q, Luo J, Yang MQ, et al., 2020. iNOS\/NO is required for IRF1 activation in response to liver ischemia-reperfusion in mice. Mol Med, 26:56. https:\/\/doi.org\/10.1186\/s10020-020-00182-2","journal-title":"Mol Med"},{"key":"749_CR24","doi-asserted-by":"publisher","first-page":"13225","DOI":"10.1038\/s41598-018-31658-1","volume":"8","author":"K Ebine","year":"2018","unstructured":"Ebine K, Kumar K, Pham TN, et al., 2018. Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cells. Sci Rep, 8:13225. https:\/\/doi.org\/10.1038\/s41598-018-31658-1","journal-title":"Sci Rep"},{"issue":"7945","key":"749_CR25","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/d41586-023-00178-y","volume":"613","author":"M Eisenstein","year":"2023","unstructured":"Eisenstein M, 2023. Seven technologies to watch in 2023. Nature, 613(7945):794\u2013797. https:\/\/doi.org\/10.1038\/d41586-023-00178-y","journal-title":"Nature"},{"issue":"3","key":"749_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.trim.2004.06.003","volume":"13","author":"L Erickson","year":"2004","unstructured":"Erickson L, Crews G, Pan F, et al., 2004. Unique gene expression profiles of heart allograft rejection in the interferon regulatory factor-1-deficient mouse. Transpl Immunol, 13(3): 169\u2013175. https:\/\/doi.org\/10.1016\/j.trim.2004.06.003","journal-title":"Transpl Immunol"},{"issue":"24","key":"749_CR27","doi-asserted-by":"publisher","first-page":"9936","DOI":"10.1073\/pnas.86.24.9936","volume":"86","author":"T Fujita","year":"1989","unstructured":"Fujita T, Reis LF, Watanabe N, et al., 1989. Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci USA, 86(24):9936\u20139940. https:\/\/doi.org\/10.1073\/pnas.86.24.9936","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"749_CR28","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/v15051080","volume":"15","author":"F Gabrielli","year":"2023","unstructured":"Gabrielli F, Alberti F, Russo C, et al., 2023. Treatment options for hepatitis A and E: a non-systematic review. Viruses, 15(5): 1080. https:\/\/doi.org\/10.3390\/v15051080","journal-title":"Viruses"},{"key":"749_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s13287-021-02476-6","volume":"12","author":"M Goonetilleke","year":"2021","unstructured":"Goonetilleke M, Kuk N, Correia J, et al., 2021. Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis using amniotic epithelial cells. Stem Cell Res Ther, 12:429. https:\/\/doi.org\/10.1186\/s13287-021-02476-6","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"749_CR30","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jid.2023.01.008","volume":"143","author":"JJ Gu","year":"2023","unstructured":"Gu JJ, Deng CC, Feng QL, et al., 2023. Relief of extracellular matrix deposition repression by downregulation of IRF1-mediated TWEAK\/Fn14 signaling in keloids. J Invest Dermatol, 143(7):1208\u20131219.e6. https:\/\/doi.org\/10.1016\/j.jid.2023.0L008","journal-title":"J Invest Dermatol"},{"issue":"6","key":"749_CR31","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1128\/JVI.76.6.2617-2621.2002","volume":"76","author":"LG Guidotti","year":"2002","unstructured":"Guidotti LG, Morris A, Mendez H, et al., 2002. Interferonregulated pathways that control hepatitis B virus replication in transgenic mice. J Virol, 76(6):2617\u20132621. https:\/\/doi.org\/10.1128\/jvi.76.6.2617-2621.2002","journal-title":"J Virol"},{"key":"749_CR32","doi-asserted-by":"publisher","first-page":"1126497","DOI":"10.3389\/fimmu.2023.1126497","volume":"14","author":"JY Guo","year":"2023","unstructured":"Guo JY, Han ST, Chen Q, et al., 2023. Analysis of potential immune-related genes involved in the pathogenesis of ischemia-reperfusion injury following liver transplantation. Front Immunol, 14:1126497. https:\/\/doi.org\/10.3389\/fimmu.2023.1126497","journal-title":"Front Immunol"},{"key":"749_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cytogfr.2017.08.002","volume":"38","author":"Y Guo","year":"2017","unstructured":"Guo Y, Luan LM, Patil NK, et al., 2017. Immunobiology of the IL-15\/IL-15R\u03b1 complex as an antitumor and antiviral agent. Cytokine Growth Factor Rev, 38:10\u201321. https:\/\/doi.org\/10.1016\/j.cytogfr.2017.08.002","journal-title":"Cytokine Growth Factor Rev"},{"issue":"51","key":"749_CR34","doi-asserted-by":"publisher","first-page":"e18442","DOI":"10.1097\/MD.0000000000018442","volume":"98","author":"YN Guo","year":"2019","unstructured":"Guo YN, Lu H, Xu L, et al., 2019. The response of hepatitis B virus genotype to interferon is associated with a mutation in the interferon-stimulated response element. Medicine (Baltimore), 98(51):e18442. https:\/\/doi.org\/10.1097\/MD.0000000000018442","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"749_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/vaccines9030215","volume":"9","author":"Z Hajikhezri","year":"2021","unstructured":"Hajikhezri Z, Roohvand F, Maleki M, et al., 2021. HCV core\/NS3 protein immunization with \u201cN-terminal heat shock gp96 protein (rNT (gp96))\u201d induced strong and sustained Th1-type cytokines in immunized mice. Vaccines (Basel), 9(3):215. https:\/\/doi.org\/10.3390\/vaccines9030215","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"749_CR36","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/lt.21708","volume":"15","author":"N Hama","year":"2009","unstructured":"Hama N, Yanagisawa Y, Dono K, et al., 2009. Gene expression profiling of acute cellular rejection in rat liver transplantation using DNA microarrays. Liver Transpl, 15(5):509\u2013521. https:\/\/doi.org\/10.1002\/lt.21708","journal-title":"Liver Transpl"},{"issue":"2","key":"749_CR37","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1128\/mcb.14.2.1500-1509.1994","volume":"14","author":"H Harada","year":"1994","unstructured":"Harada H, Takahashi EI, Itoh S, et al., 1994. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system. Mol Cell Biol, 14(2):1500\u20131509. https:\/\/doi.org\/10.1128\/mcb.14.2.1500-1509.1994","journal-title":"Mol Cell Biol"},{"issue":"9","key":"749_CR38","doi-asserted-by":"publisher","first-page":"e1008840","DOI":"10.1371\/journal.ppat.1008840","volume":"16","author":"NS Hojo-Souza","year":"2020","unstructured":"Hojo-Souza NS, de Azevedo PO, de Castro JT, et al., 2020. Contributions of IFN-\u03b3 and granulysin to the clearance of Plasmodium yoelii blood stage. PLoS Pathog, 16(9): e1008840. https:\/\/doi.org\/10.1371\/journal.ppat.1008840","journal-title":"PLoS Pathog"},{"issue":"10","key":"749_CR39","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1365-2893.2006.00732.x","volume":"13","author":"Y Itsui","year":"2006","unstructured":"Itsui Y, Sakamoto N, Kurosaki M, et al., 2006. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat, 13(10):690\u2013700. https:\/\/doi.org\/10.1111\/j.1365-2893.2006.00732.x","journal-title":"J Viral Hepat"},{"issue":"6","key":"749_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.6002\/ect.2015.0302","volume":"15","author":"S Janfeshan","year":"2017","unstructured":"Janfeshan S, Yaghobi R, Eidi A, et al., 2017. Expression profile of interferon regulatory factor 1 in chronic hepatitis B virus-infected liver transplant patients. Exp Clin Transplant, 15(6):669\u2013675. https:\/\/doi.org\/10.6002\/ect.2015.0302","journal-title":"Exp Clin Transplant"},{"issue":"10381","key":"749_CR41","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","volume":"401","author":"WJ Jeng","year":"2023","unstructured":"Jeng WJ, Papatheodoridis GV, Lok ASF, 2023. Hepatitis B. Lancet, 401(10381):1039\u20131052. https:\/\/doi.org\/10.1016\/S0140-6736(22)01468-4","journal-title":"Lancet"},{"issue":"6","key":"749_CR42","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/hep.21419","volume":"44","author":"WI Jeong","year":"2006","unstructured":"Jeong WI, Park O, Radaeva S, et al., 2006. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology, 44(6):1441\u20131451. https:\/\/doi.org\/10.1002\/hep.21419","journal-title":"Hepatology"},{"issue":"1","key":"749_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/cbin.11713","volume":"46","author":"WL Jiang","year":"2022","unstructured":"Jiang WL, Chen GX, Pu J, 2022. The transcription factor interferon regulatory factor-1 is an endogenous mediator of myocardial ischemia reperfusion injury. Cell Biol Int, 46(1): 63\u201372. https:\/\/doi.org\/10.1002\/cbin.11713","journal-title":"Cell Biol Int"},{"issue":"2","key":"749_CR44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.virusres.2007.07.005","volume":"129","author":"CR Jung","year":"2007","unstructured":"Jung CR, Choi S, Im DS, 2007. The NS5A protein of hepatitis C virus represses gene expression of hRPB10a, a common subunit of host RNA polymerases, through interferon regulatory factor-1 binding site. Virus Res, 129(2):155\u2013165. https:\/\/doi.org\/10.1016\/j.virusres.2007.07.005","journal-title":"Virus Res"},{"issue":"18","key":"749_CR45","doi-asserted-by":"publisher","first-page":"9713","DOI":"10.1128\/JVI.78.18.9713-9720.2004","volume":"78","author":"N Kanazawa","year":"2004","unstructured":"Kanazawa N, Kurosaki M, Sakamoto N, et al., 2004. Regulation of hepatitis C virus replication by interferon regulatory factor 1. J Virol, 78(18):9713\u20139720. https:\/\/doi.org\/10.1128\/JVI.78.18.9713-9720.2004","journal-title":"J Virol"},{"issue":"10","key":"749_CR46","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1097\/00007890-200005270-00030","volume":"69","author":"ML Kielar","year":"2000","unstructured":"Kielar ML, Jeyarajah DR, Penfield JG, et al., 2000. Docosahexaenoic acid decreases IRF-1 mRNA and thus inhibits activation of both the IRF-E and NFKd response elements of the iNOS promoter. Transplantation, 69(10):2131\u20132137. https:\/\/doi.org\/10.1097\/00007890-200005270-00030","journal-title":"Transplantation"},{"issue":"2","key":"749_CR47","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/hep.31313","volume":"73","author":"GW Kim","year":"2021","unstructured":"Kim GW, Imam H, Khan M, et al., 2021. HBV-induced increased N6 methyladenosine modification of PTEN RNA affects innate immunity and contributes to HCC. Hepatology, 73(2):533\u2013547. https:\/\/doi.org\/10.1002\/hep.31313","journal-title":"Hepatology"},{"issue":"18","key":"749_CR48","doi-asserted-by":"publisher","first-page":"9919","DOI":"10.1128\/JVI.00388-12","volume":"86","author":"H Kim","year":"2012","unstructured":"Kim H, Mazumdar B, Bose SK, et al., 2012. Hepatitis C virusmediated inhibition of cathepsin S increases invariant-chain expression on hepatocyte surface. J Virol, 86(18):9919\u20139928. https:\/\/doi.org\/10.1128\/JVI.00388-12","journal-title":"J Virol"},{"issue":"2","key":"749_CR49","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.surg.2009.06.011","volume":"146","author":"KH Kim","year":"2009","unstructured":"Kim KH, Dhupar R, Ueki S, et al., 2009. Donor graft interferon regulatory factor-1 gene transfer worsens liver transplant ischemia\/reperfusion injury. Surgery, 146(2):181\u2013189. https:\/\/doi.org\/10.1016\/j.surg.2009.06.011","journal-title":"Surgery"},{"issue":"3","key":"749_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D, 2021. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol, 18(3): 151\u2013166. https:\/\/doi.org\/10.1038\/s41575-020-00372-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"749_CR51","doi-asserted-by":"publisher","first-page":"G991","DOI":"10.1152\/ajpgi.00231.2018","volume":"315","author":"JR Klune","year":"2018","unstructured":"Klune JR, Bartels C, Luo J, et al., 2018. IL-23 mediates murine liver transplantation ischemia-reperfusion injury via IFN-\u03b3\/IRF-1 pathway. Am J Physiol Gastrointest Liver Physiol, 315(6):G991\u2013G1002. https:\/\/doi.org\/10.1152\/ajpgi.00231.2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"749_CR52","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jhep.2020.07.039","volume":"74","author":"RM Komoll","year":"2021","unstructured":"Komoll RM, Hu QL, Olarewaju O, et al., 2021. MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma. J Hepatol, 74(1):122\u2013134. https:\/\/doi.org\/10.1016\/j.jhep.2020.07.039","journal-title":"J Hepatol"},{"issue":"1","key":"749_CR53","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.ijid.2012.08.004","volume":"17","author":"M Korachi","year":"2013","unstructured":"Korachi M, Ceran N, Adaleti R, et al., 2013. An association study of functional polymorphic genes IRF-1, IFNGR-1, and IFN-\u03b3 with disease progression, aspartate aminotransferase, alanine aminotransferase, and viral load in chronic hepatitis B and C. Int J Infect Dis, 17(1):e44\u2013e49. https:\/\/doi.org\/10.1016\/j.ijid.2012.08.004","journal-title":"Int J Infect Dis"},{"issue":"1","key":"749_CR54","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ajpath.2013.03.018","volume":"183","author":"K Kuramitsu","year":"2013","unstructured":"Kuramitsu K, Sverdlov DY, Liu SB, et al., 2013. Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation. Am J Pathol, 183(1):182\u2013194. https:\/\/doi.org\/10.1016\/j.ajpath.2013.03.018","journal-title":"Am J Pathol"},{"key":"749_CR55","doi-asserted-by":"publisher","first-page":"154950","DOI":"10.1016\/j.phymed.2023.154950","volume":"118","author":"ZC Lang","year":"2023","unstructured":"Lang ZC, Yu SH, Hu YH, et al., 2023. Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11. Phytomedicine, 118:154950. https:\/\/doi.org\/10.1016\/j.phymed.2023.154950","journal-title":"Phytomedicine"},{"issue":"3","key":"749_CR56","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sj.onc.1206133","volume":"22","author":"SH Lee","year":"2003","unstructured":"Lee SH, Kim JW, Lee HW, et al., 2003. Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-\u03b3 induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression. Oncogene, 22(3): 381\u2013391. https:\/\/doi.org\/10.1038\/sj.onc.1206133","journal-title":"Oncogene"},{"issue":"5","key":"749_CR57","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/hep.32456","volume":"76","author":"L Lei","year":"2022","unstructured":"Lei L, Bruneau A, el Mourabit H, et al., 2022. Portal fibro-blasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis. Hepatology, 76(5):1360\u20131375. https:\/\/doi.org\/10.1002\/hep.32456","journal-title":"Hepatology"},{"issue":"2","key":"749_CR58","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/HEP.0000000000000531","volume":"79","author":"HD Li","year":"2024","unstructured":"Li HD, Chen X, Xu JJ, et al., 2024. GRP\/GRPR enhances alcohol-associated liver injury via the IRF1-mediated Caspase-1 in-flammasome and NOX2-dependent ROS pathway. Hepatology, 79(2):392\u2013408. https:\/\/doi.org\/10.1097\/HEP.0000000000000531","journal-title":"Hepatology"},{"issue":"3","key":"749_CR59","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s10753-023-01792-8","volume":"46","author":"K Li","year":"2023","unstructured":"Li K, Feng ZJ, Wang LS, et al., 2023. Chlorogenic acid alleviates hepatic ischemia-reperfusion injury by inhibiting oxidative stress, inflammation, and mitochondria-mediated apoptosis in vivo and in vitro. Inflammation, 46(3): 1061\u20131076. https:\/\/doi.org\/10.1007\/s10753-023-01792-8","journal-title":"Inflammation"},{"issue":"2","key":"749_CR60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.canlet.2011.09.031","volume":"314","author":"PY Li","year":"2012","unstructured":"Li PY, Du Q, Cao ZX, et al., 2012. Interferon-gamma induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1). Cancer Lett, 314(2):213\u2013222. https:\/\/doi.org\/10.1016\/j.canlet.2011.09.031","journal-title":"Cancer Lett"},{"issue":"12","key":"749_CR61","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/lt.24606","volume":"22","author":"SP Li","year":"2016","unstructured":"Li SP, Zhang JJ, Wang Z, et al., 2016. MicroRNA-17 regulates autophagy to promote hepatic ischemia\/reperfusion injury via suppression of signal transductions and activation of transcription-3 expression. Liver Transpl, 22(12):1697\u20131709. https:\/\/doi.org\/10.1002\/lt.24606","journal-title":"Liver Transpl"},{"issue":"1","key":"749_CR62","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/mco2.58","volume":"2","author":"SP Li","year":"2021","unstructured":"Li SP, He JD, Xu HW, et al., 2021. Autophagic activation of IRF-1 aggravates hepatic ischemia-reperfusion injury via JNK signaling. MedComm, 2(1):91\u2013100. https:\/\/doi.org\/10.1002\/mco2.58","journal-title":"MedComm"},{"issue":"3","key":"749_CR63","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/cancers15030850","volume":"15","author":"XC Li","year":"2023","unstructured":"Li XC, Huang JQ, Wu QL, et al., 2023. Inhibition of checkpoint kinase 1 (CHK1) upregulates interferon regulatory factor 1 (IRF1) to promote apoptosis and activate anti-tumor immunity via MICA in hepatocellular carcinoma (HCC). Cancers (Basel), 15(3):850. https:\/\/doi.org\/10.3390\/cancers15030850","journal-title":"Cancers (Basel)"},{"key":"749_CR64","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fimmu.2016.00569","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Wu Y, Zheng XH, et al., 2016. Cytoplasm-translocated Ku70\/80 complex sensing of HBV DNA induces hepatitis-associated chemokine secretion. Front Immunol, 7:569. https:\/\/doi.org\/10.3389\/fimmu.2016.00569","journal-title":"Front Immunol"},{"issue":"33","key":"749_CR65","doi-asserted-by":"publisher","first-page":"12359","DOI":"10.1074\/jbc.RA119.007409","volume":"294","author":"S Liang","year":"2019","unstructured":"Liang S, Zhong ZY, Kim SY, et al., 2019. Murine macrophage autophagy protects against alcohol-induced liver injury by degrading interferon regulatory factor 1 (IRF1) and removing damaged mitochondria. J Biol Chem, 294(33): 12359\u201312369. https:\/\/doi.org\/10.1074\/jbc.RA119.007409","journal-title":"J Biol Chem"},{"issue":"6","key":"749_CR66","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.jhep.2014.12.035","volume":"62","author":"YH Lin","year":"2015","unstructured":"Lin YH, Wu MH, Liao CJ, et al., 2015. Repression of microRNA-130b by thyroid hormone enhances cell motility. J Hepatol, 62(6):1328\u20131340. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.035","journal-title":"J Hepatol"},{"issue":"1","key":"749_CR67","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000484920","volume":"44","author":"FH Liu","year":"2017","unstructured":"Liu FH, Ni WJ, Zhang JJ, et al., 2017. Administration of curcumin protects kidney tubules against renal ischemia-reperfusion injury (RIRI) by modulating nitric oxide (NO) signaling pathway. Cell Physiol Biochem, 44(1):401\u2013411. https:\/\/doi.org\/10.1159\/000484920","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"749_CR68","doi-asserted-by":"publisher","first-page":"e1405142","DOI":"10.1080\/23723556.2017.1405142","volume":"5","author":"K Liu","year":"2018","unstructured":"Liu K, Lee J, Ou JHJ, 2018. Autophagy and mitophagy in hepatocarcinogenesis. Mol Cell Oncol, 5(2):e1405142. https:\/\/doi.org\/10.1080\/23723556.2017.1405142","journal-title":"Mol Cell Oncol"},{"issue":"6","key":"749_CR69","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1053\/j.gastro.2020.01.027","volume":"158","author":"X Liu","year":"2020","unstructured":"Liu X, Xu J, Rosenthal S, et al., 2020. Identification of lineage-specific transcription factors that prevent activation of hepatic stellate cells and promote fibrosis resolution. Gastroenterology, 158(6):1728\u20131744.e14. https:\/\/doi.org\/10.1053\/j.gastro.2020.01.027","journal-title":"Gastroenterology"},{"issue":"3","key":"749_CR70","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.3892\/ol.2018.9032","volume":"16","author":"C Lu","year":"2018","unstructured":"Lu C, Peng K, Guo H, et al., 2018. miR-18a-5p promotes cell invasion and migration of osteosarcoma by directly targeting IRF2. Oncol Lett, 16(3):3150\u20133156. https:\/\/doi.org\/10.3892\/ol.2018.9032","journal-title":"Oncol Lett"},{"issue":"1","key":"749_CR71","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.gde.2010.12.008","volume":"21","author":"R Mathew","year":"2011","unstructured":"Mathew R, White E, 2011. Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Curr Opin GenetDev, 21(1):113\u2013119. https:\/\/doi.org\/10.1016\/j.gde.2010.12.008","journal-title":"Curr Opin GenetDev"},{"issue":"3","key":"749_CR72","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1006\/bbrc.1998.8712","volume":"246","author":"M Miyazaki","year":"1998","unstructured":"Miyazaki M, Ohashi R, Tsuji T, et al., 1998. Transforming growth factor-\u03b21 stimulates or inhibits cell growth via down- or up-regulation of p21\/Waf1. Biochem Biophys Res Commun, 246(3):873\u2013880. https:\/\/doi.org\/10.1006\/bbrc.1998.8712","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"749_CR73","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1158\/0008-5472.CAN-03-2750","volume":"64","author":"M Miyazaki","year":"2004","unstructured":"Miyazaki M, Sakaguchi M, Akiyama I, et al., 2004. Involvement of interferon regulatory factor 1 and S100C\/A11 in growth inhibition by transforming growth factor \u03b21 in human hepatocellular carcinoma cells. Cancer Res, 64(12): 4155\u20134161. https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-2750","journal-title":"Cancer Res"},{"issue":"1","key":"749_CR74","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/nm.4468","volume":"24","author":"SP Monga","year":"2018","unstructured":"Monga SP, 2018. Lipid metabolic reprogramming in hepatic ischemia-reperfusion injury. Nat Med, 24(1):6\u20137. https:\/\/doi.org\/10.1038\/nm.4468","journal-title":"Nat Med"},{"issue":"5","key":"749_CR75","first-page":"1293","volume":"7","author":"Y Moriyama","year":"2001","unstructured":"Moriyama Y, Nishiguchi S, Tamori A, et al., 2001. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma. Clin Cancer Res, 7(5):1293\u20131298.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"749_CR76","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1006\/bbrc.2000.2256","volume":"269","author":"A Moro","year":"2000","unstructured":"Moro A, Santos A, Ara\u00f1a MJ, et al., 2000. Activation of the human p27Kip1 promoter by IFNa 2b. Biochem Biophys Res Commun, 269(1):31\u201334. https:\/\/doi.org\/10.1006\/bbrc.2000.2256","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"749_CR77","first-page":"68","volume":"9","author":"SH Nabavizadeh","year":"2018","unstructured":"Nabavizadeh SH, Janfeshan S, Karimi MH, et al., 2018. Association between IRF1 gene expression and liver enzymes in HBV-infected liver transplant recipients with and without experience of rejection. Int J Organ Transplant Med, 9(2):68\u201374","journal-title":"Int J Organ Transplant Med"},{"issue":"1","key":"749_CR78","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s40472-019-0230-4","volume":"6","author":"K Nakamura","year":"2019","unstructured":"Nakamura K, Kageyama S, Kupiec-Weglinski JW, 2019. The evolving role of neutrophils in liver transplant ischemia-reperfusion injury. Curr Transplant Rep, 6(1):78\u201389. https:\/\/doi.org\/10.1007\/s40472-019-0230-4","journal-title":"Curr Transplant Rep"},{"issue":"40","key":"749_CR79","doi-asserted-by":"publisher","first-page":"28075","DOI":"10.1074\/jbc.274.40.28075","volume":"274","author":"K Nakao","year":"1999","unstructured":"Nakao K, Nakata K, Yamashita M, et al., 1999. p48 (ISGF-3\u03b3) is involved in interferon-a-induced suppression of hepatitis B virus enhancer-1 activity. J Biol Chem, 274(40):28075\u201328078. https:\/\/doi.org\/10.1074\/jbc.274.40.28075","journal-title":"J Biol Chem"},{"issue":"6","key":"749_CR80","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1053\/j.gastro.2013.08.037","volume":"145","author":"R Nandakumar","year":"2013","unstructured":"Nandakumar R, Finsterbusch K, Lipps C, et al., 2013. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms. Gastroenterology, 145(6):1414\u20131423.e1. https:\/\/doi.org\/10.1053\/j.gastro.2013.08.037","journal-title":"Gastroenterology"},{"issue":"40","key":"749_CR81","doi-asserted-by":"publisher","first-page":"1902956","DOI":"10.1002\/adma.201902956","volume":"31","author":"DL Ni","year":"2019","unstructured":"Ni DL, Wei H, Chen WY, et al., 2019. Ceria nanoparticles meet hepatic ischemia-reperfusion injury: the perfect imperfection. AdvMater, 31(40):1902956. https:\/\/doi.org\/10.1002\/adma.201902956","journal-title":"AdvMater"},{"issue":"5","key":"749_CR82","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/JLB.3MR0121-277R","volume":"110","author":"YA Ni","year":"2021","unstructured":"Ni YA, Chen H, Nie H, et al., 2021. HMGB1: an overview of its roles in the pathogenesis of liver disease. J Leukoc Biol, 110(5):987\u2013998. https:\/\/doi.org\/10.1002\/JLB.3MR0121-277R","journal-title":"J Leukoc Biol"},{"issue":"2","key":"749_CR83","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3892\/ijmm.2017.3043","volume":"40","author":"JE Oh","year":"2017","unstructured":"Oh JE, Shim KY, Lee JI, et al., 2017. 1-Methyl-L-tryptophan promotes the apoptosis of hepatic stellate cells arrested by interferon-\u03b3 by increasing the expression of IFN-\u03b3R\u03b2, IRF-1 and FAS. Int J Mol Med, 40(2):576\u2013582. https:\/\/doi.org\/10.3892\/ijmm.2017.3043","journal-title":"Int J Mol Med"},{"issue":"20","key":"749_CR84","doi-asserted-by":"publisher","first-page":"e01015","DOI":"10.1128\/JVI.01015-18","volume":"92","author":"S Pan","year":"2018","unstructured":"Pan S, Liu X, Ma YJ, et al., 2018. Herpes simplex virus 1 \u03b3134.5 protein inhibits STING activation that restricts viral replication. J Virol, 92(20):e01015\u201318. https:\/\/doi.org\/10.1128\/JVI.01015-18","journal-title":"J Virol"},{"key":"749_CR85","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.intimp.2016.06.013","volume":"38","author":"XL Pang","year":"2016","unstructured":"Pang XL, Wang ZX, Zhai NC, et al., 2016. IL-10 plays a central regulatory role in the cytokines induced by hepatitis C virus core protein and polyinosinic acid: polycytodylic acid. Int Immunopharmacol, 38:284\u2013290. https:\/\/doi.org\/10.1016\/j.intimp.2016.06.013","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"749_CR86","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.jhep.2015.10.016","volume":"64","author":"S Petta","year":"2016","unstructured":"Petta S, Valenti L, Marra F, et al., 2016. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease. J Hepatol, 64(3):682\u2013690. https:\/\/doi.org\/10.1016\/j.jhep.2015.10.016","journal-title":"J Hepatol"},{"issue":"5","key":"749_CR87","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","volume":"7","author":"The Polaris Observatory HCV Collaborators","year":"2022","unstructured":"The Polaris Observatory HCV Collaborators, 2022. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol, 7(5):396\u2013415. https:\/\/doi.org\/10.1016\/S2468-1253(21)00472-6","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"749_CR88","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.bbrc.2019.03.133","volume":"512","author":"YL Qiao","year":"2019","unstructured":"Qiao YL, Zhang XL, Zhao GM, et al., 2019. Hepatocellular iNOS protects liver from ischemia\/reperfusion injury through HSF1-dependent activation of HSP70. Biochem Biophys Res Commun, 512(4):882\u2013888. https:\/\/doi.org\/10.1016\/j.bbrc.2019.03.133","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"749_CR89","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.bbrc.2019.11.053","volume":"521","author":"YL Qiao","year":"2020","unstructured":"Qiao YL, Xiao F, Li WK, et al., 2020. Hepatocellular HO-1 mediated iNOS-induced hepatoprotection against liver ischemia reperfusion injury. Biochem Biophys Res Commun, 521(4):1095\u20131100. https:\/\/doi.org\/10.1016\/j.bbrc.2019.11.053","journal-title":"Biochem Biophys Res Commun"},{"issue":"48","key":"749_CR90","doi-asserted-by":"publisher","first-page":"18466","DOI":"10.1074\/jbc.RA118.005583","volume":"293","author":"R Rani","year":"2018","unstructured":"Rani R, Kumar S, Sharma A, et al., 2018. Mechanisms of concanavalin A-induced cytokine synthesis by hepatic stellate cells: distinct roles of interferon regulatory factor-1 in liver injury. JBiol Chem, 293(48):18466\u201318476. https:\/\/doi.org\/10.1074\/jbc.RA118.005583","journal-title":"JBiol Chem"},{"issue":"3","key":"749_CR91","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.cell.2022.12.038","volume":"186","author":"J Rosain","year":"2023","unstructured":"Rosain J, Neehus AL, Manry J, et al., 2023. Human IRF1 governs macrophagic IFN- y immunity to mycobacteria. Cell, 186(3):621\u2013645.e33. https:\/\/doi.org\/10.1016\/j.cell.2022.12.038","journal-title":"Cell"},{"key":"749_CR92","doi-asserted-by":"publisher","first-page":"581352","DOI":"10.3389\/fimmu.2020.581352","volume":"11","author":"S Rueschenbaum","year":"2021","unstructured":"Rueschenbaum S, Cai CC, Schmidt M, et al., 2021. Translation of IRF-1 restricts hepatic interleukin-7 production to types I and II interferons: implications for hepatic immunity. Front Immunol, 11:581352. https:\/\/doi.org\/10.3389\/fimmu.2020.581352","journal-title":"Front Immunol"},{"issue":"1","key":"749_CR93","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.hepres.2005.03.009","volume":"32","author":"H Saito","year":"2005","unstructured":"Saito H, Tada S, Nakamoto N, et al., 2005. Contribution of Irf-1 promoter polymorphisms to the Th1-type cell response and interferon-\u03b2 monotherapy for chronic hepatitis C. Hepatol Res, 32(1):25\u201332. https:\/\/doi.org\/10.1016\/j.hepres.2005.03.009","journal-title":"Hepatol Res"},{"issue":"3","key":"749_CR94","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1478-3231.2008.01835.x","volume":"29","author":"H Shi","year":"2009","unstructured":"Shi H, Guan SH, 2009. Increased apoptosis in HepG2.2.15 cells with hepatitis B virus expression by synergistic induction of interferon-\u03b3 and tumour necrosis factor-a. Liver Int, 29(3): 349\u2013355. https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01835.x","journal-title":"Liver Int"},{"issue":"3","key":"749_CR95","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.trim.2010.11.007","volume":"24","author":"M Solomon","year":"2011","unstructured":"Solomon M, Flodstr\u00f6m-Tullberg M, Sarvetnick N, 2011. Beta-cell specific expression of suppressor of cytokine signaling-1 (SOCS-1 ) delays islet allograft rejection by down-regulating Interferon Regulatory Factor-1 (IRF-1) signaling. Transpl Immunol, 24(3): 181\u2013188. https:\/\/doi.org\/10.1016\/j.trim.2010.11.007","journal-title":"Transpl Immunol"},{"key":"749_CR96","doi-asserted-by":"publisher","first-page":"778329","DOI":"10.3389\/fimmu.2021.778329","volume":"12","author":"C Sorrentino","year":"2021","unstructured":"Sorrentino C, D\u2019Antonio L, Fieni C, et al., 2021. Colorectal cancer-associated immune exhaustion involves T and B lymphocytes and conventional NK cells and correlates with a shorter overall survival. Front Immunol, 12:778329. https:\/\/doi.org\/10.3389\/fimmu.2021.778329","journal-title":"Front Immunol"},{"key":"749_CR97","doi-asserted-by":"publisher","first-page":"101414","DOI":"10.1016\/j.trim.2021.101414","volume":"68","author":"M Soyoz","year":"2021","unstructured":"Soyoz M, Pehlivan M, Tatar E, et al., 2021. Consideration of IL-2, IFN-\u03b3 and IL-4 expression and methylation levels in CD4+ T cells as a predictor of rejection in kidney transplant. Transpl Immunol, 68:101414. https:\/\/doi.org\/10.1016\/j.trim.2021.101414","journal-title":"Transpl Immunol"},{"issue":"6","key":"749_CR98","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/ijc.32196","volume":"145","author":"B Sun","year":"2019","unstructured":"Sun B, Zhou YM, Fang YT, et al., 2019. Colorectal cancer exosomes induce lymphatic network remodeling in lymph nodes. Int J Cancer, 145(6): 1648\u20131659. https:\/\/doi.org\/10.1002\/ijc.32196","journal-title":"Int J Cancer"},{"issue":"2","key":"749_CR99","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3748\/wjg.v24.i2.248","volume":"24","author":"BT Sy","year":"2018","unstructured":"Sy BT, Hoan NX, Tong HV, et al., 2018. Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection. World J Gastroenterol, 24(2):248\u2013256. https:\/\/doi.org\/10.3748\/wjg.v24.i2.248","journal-title":"World J Gastroenterol"},{"issue":"6","key":"749_CR100","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.3892\/ijo.13.6.1207","volume":"13","author":"S Tada","year":"1998","unstructured":"Tada S, Saito H, Tsunematsu S, et al., 1998. Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines. Int J Oncol, 13(6):1207\u20131216. https:\/\/doi.org\/10.3892\/ijo.13.6.1207","journal-title":"Int J Oncol"},{"key":"749_CR101","doi-asserted-by":"publisher","first-page":"104748","DOI":"10.1016\/j.antiviral.2020.104748","volume":"176","author":"AT Tan","year":"2020","unstructured":"Tan AT, Schreiber S, 2020. Adoptive T-cell therapy for HBV-associated HCC and HBV infection. Antiviral Res, 176: 104748. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104748","journal-title":"Antiviral Res"},{"key":"749_CR102","doi-asserted-by":"publisher","first-page":"623280","DOI":"10.3389\/fimmu.2021.623280","volume":"12","author":"HS Tao","year":"2021","unstructured":"Tao HS, Li L, Liao NS, et al., 2021. Thymic epithelial cell-derived IL-15 and IL-15 receptor a chain foster local environment for type 1 innate like T cell development. Front Immunol, 12:623280. https:\/\/doi.org\/10.3389\/fimmu.2021.623280","journal-title":"Front Immunol"},{"issue":"1","key":"749_CR103","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40121-021-00578-5","volume":"11","author":"E Thomas","year":"2022","unstructured":"Thomas E, Cheng WH, Dylla DE, et al., 2022. Awareness and epidemiology of chronic hepatitis C virus infections in florida. Infect Dis Ther, 11(1):451\u2013462. https:\/\/doi.org\/10.1007\/s40121-021-00578-5","journal-title":"Infect Dis Ther"},{"issue":"9","key":"749_CR104","doi-asserted-by":"publisher","first-page":"e48891","DOI":"10.15252\/embr.201948891","volume":"20","author":"SJ Thygesen","year":"2019","unstructured":"Thygesen SJ, Stacey KJ, 2019. IRF1 and IRF2 regulate the non-canonical inflammasome. EMBO Rep, 20(9):e48891. https:\/\/doi.org\/10.15252\/embr.201948891","journal-title":"EMBO Rep"},{"key":"749_CR105","doi-asserted-by":"publisher","first-page":"109481","DOI":"10.1016\/j.biopha.2019.109481","volume":"120","author":"XH Tian","year":"2019","unstructured":"Tian XH, Liu Y, Liu XL, et al., 2019. Glycyrrhizic acid ammonium salt alleviates Concanavalin A-induced immunological liver injury in mice through the regulation of the balance of immune cells and the inhibition of hepatocyte apoptosis. Biomed Pharmacother, 120:109481. https:\/\/doi.org\/10.1016\/j.biopha.2019.109481","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"749_CR106","doi-asserted-by":"publisher","first-page":"G1261","DOI":"10.1152\/ajpgi.00460.2005","volume":"290","author":"A Tsung","year":"2006","unstructured":"Tsung A, Stang MT, Ikeda A, et al., 2006. The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol, 290(6):G1261\u2013G1268. https:\/\/doi.org\/10.1152\/ajpgi.00460.2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"12","key":"749_CR107","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1084\/jem.20070247","volume":"204","author":"A Tsung","year":"2007","unstructured":"Tsung A, Klune JR, Zhang XH, et al., 2007. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med, 204(12):2913\u20132923. https:\/\/doi.org\/10.1084\/jem.20070247","journal-title":"J Exp Med"},{"issue":"5","key":"749_CR108","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1002\/hep.23501","volume":"51","author":"S Ueki","year":"2010","unstructured":"Ueki S, Dhupar R, Cardinal J, et al., 2010. Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injury. Hepatology, 51(5): 1692\u20131701. https:\/\/doi.org\/10.1002\/hep.23501","journal-title":"Hepatology"},{"issue":"15","key":"749_CR109","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A, 2019. Hepatocellular carcinoma. N Engl J Med, 380(15):1450\u20131462. https:\/\/doi.org\/10.1056\/NEJMra1713263","journal-title":"N Engl J Med"},{"key":"749_CR110","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.biopha.2017.10.096","volume":"97","author":"PQ Wan","year":"2018","unstructured":"Wan PQ, Zhang JH, Du Q, et al., 2018a. The clinical significance and biological function of interferon regulatory factor 1 in cholangiocarcinoma. Biomed Pharmacother, 97:771\u2013777. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.096","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"749_CR111","doi-asserted-by":"publisher","first-page":"9720","DOI":"10.1002\/jcb.27286","volume":"119","author":"PQ Wan","year":"2018","unstructured":"Wan PQ, Chi X, Du Q, et al., 2018b. miR-383 promotes cholangiocarcinoma cell proliferation, migration, and invasion through targeting IRF1. J Cell Biochem, 119(12):9720\u20139729. https:\/\/doi.org\/10.1002\/jcb.27286","journal-title":"J Cell Biochem"},{"issue":"2","key":"749_CR112","doi-asserted-by":"publisher","first-page":"647","DOI":"10.26355\/eurrev_202001_20041","volume":"24","author":"PQ Wan","year":"2020","unstructured":"Wan PQ, Zhang JH, Du Q, et al., 2020. Analysis of the relationship between microRNA-31 and interferon regulatory factor-1 in hepatocellular carcinoma cells. Eur Rev Med Pharmacol Sci, 24(2):647\u2013654. https:\/\/doi.org\/10.26355\/eurrev_202001_20041","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"19","key":"749_CR113","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1002\/1873-3468.13887","volume":"594","author":"DP Wang","year":"2020","unstructured":"Wang DP, Yu ZX, He ZC, et al., 2020. Apolipoprotein L1 is transcriptionally regulated by SP1, IRF1 and IRF2 in hepatoma cells. FEBSLett, 594(19):3108\u20133121. https:\/\/doi.org\/10.1002\/1873-3468.13887","journal-title":"FEBSLett"},{"issue":"22","key":"749_CR114","doi-asserted-by":"publisher","first-page":"e01231","DOI":"10.1128\/JVI.01231-20","volume":"94","author":"JJ Wang","year":"2020","unstructured":"Wang JJ, Li HY, Xue BB, et al., 2020. IRF1 promotes the innate immune response to viral infection by enhancing the activation of IRF3. J Virol, 94(22):e01231\u201320. https:\/\/doi.org\/10.1128\/JVI.01231-20","journal-title":"J Virol"},{"key":"749_CR115","doi-asserted-by":"publisher","first-page":"5578021","DOI":"10.1155\/2021\/5578021","volume":"2021","author":"MH Wang","year":"2021","unstructured":"Wang MH, Yin HL, Xia Y, et al., 2021. Huganbuzure granule attenuates concanavalin-A-induced immune liver injury in mice via regulating the balance of Th1\/Th2\/Th17\/Treg cells and inhibiting apoptosis. Evid Based Complement Alternat Med, 2021:5578021. https:\/\/doi.org\/10.1155\/2021\/5578021","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"749_CR116","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10753-021-01547-3","volume":"45","author":"R Wang","year":"2022","unstructured":"Wang R, Guo H, Tang XT, et al., 2022. Interferon gamma-induced interferon regulatory factor 1 activates transcription of HHLA2 and induces immune escape of hepatocel-lular carcinoma cells. Inflammation, 45(1):308\u2013330. https:\/\/doi.org\/10.1007\/s10753-021-01547-3","journal-title":"Inflammation"},{"issue":"776","key":"749_CR117","doi-asserted-by":"publisher","first-page":"eabq3362","DOI":"10.1126\/scisignal.abq3362","volume":"16","author":"ZB Wang","year":"2023","unstructured":"Wang ZB, Pan BL, Qiu JC, et al., 2023. SUMOylated IL-33 in the nucleus stabilizes the transcription factor IRF1 in he-patocellular carcinoma cells to promote immune escape. Sci Signal, 16(776):eabq3362. https:\/\/doi.org\/10.1126\/scisignal.abq3362","journal-title":"Sci Signal"},{"issue":"4","key":"749_CR118","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jhep.2013.05.041","volume":"59","author":"HL Weng","year":"2013","unstructured":"Weng HL, Feng DC, Radaeva S, et al., 2013. IFN-\u03b3 inhibits liver progenitor cell proliferation in HBV-infected patients and in 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-fed mice. J Hepatol, 59(4):738\u2013745. https:\/\/doi.org\/10.1016\/j.jhep.2013.05.041","journal-title":"J Hepatol"},{"issue":"9","key":"749_CR119","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1097\/01.meg.0000224478.89545.76","volume":"18","author":"P Wietzke-Braun","year":"2006","unstructured":"Wietzke-Braun P, Maouzi AB, M\u00e4nhardt LB, et al., 2006. Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection. Eur J Gastroenterol Hepatol, 18(9):991\u2013997. https:\/\/doi.org\/10.1097\/01.meg.0000224478.89545.76","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"749_CR120","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/hep.32316","volume":"76","author":"HX Wu","year":"2022","unstructured":"Wu HX, Li Y, Shi GJ, et al., 2022. Hepatic interferon regulatory factor 8 expression suppresses hepatocellular carcinoma progression and enhances the response to anti-programmed cell death protein-1 therapy. Hepatology, 76(6):1602\u20131616. https:\/\/doi.org\/10.1002\/hep.32316","journal-title":"Hepatology"},{"issue":"1","key":"749_CR121","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s40425-019-0784-9","volume":"7","author":"G Xiao","year":"2019","unstructured":"Xiao G, Jin LL, Liu CQ, et al., 2019. EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma. J Immunother Cancer, 7(1):300. https:\/\/doi.org\/10.1186\/s40425-019-0784-9","journal-title":"J Immunother Cancer"},{"issue":"10","key":"749_CR122","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1096\/fj.201600356R","volume":"30","author":"L Xu","year":"2016","unstructured":"Xu L, Zhou XY, Wang WS, et al., 2016. IFN regulatory factor 1 restricts hepatitis E virus replication by activating STAT1 to induce antiviral IFN-stimulated genes. FASEB J, 30(10): 3352\u20133367. https:\/\/doi.org\/10.1096\/fj.201600356R","journal-title":"FASEB J"},{"issue":"6","key":"749_CR123","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1002\/hep.29105","volume":"65","author":"L Xu","year":"2017","unstructured":"Xu L, Wang WS, Li YL, et al., 2017. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production. Hepatology, 65(6):1823\u20131839. https:\/\/doi.org\/10.1002\/hep.29105","journal-title":"Hepatology"},{"issue":"7","key":"749_CR124","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41564-019-0425-6","volume":"4","author":"D Yamane","year":"2019","unstructured":"Yamane D, Feng H, Rivera-Serrano EE, et al., 2019. Basal expression of interferon regulatory factor 1 drives intrinsic hepatocyte resistance to multiple RNA viruses. Nat Microbiol, 4(7):1096\u20131104. https:\/\/doi.org\/10.1038\/s41564-019-0425-6","journal-title":"Nat Microbiol"},{"issue":"11","key":"749_CR125","doi-asserted-by":"publisher","first-page":"e0239119","DOI":"10.1371\/journal.pone.0239119","volume":"15","author":"B Yan","year":"2020","unstructured":"Yan B, Luo J, Kaltenmeier C, et al., 2020. Interferon Regulatory Factor-1 (IRF1) activates autophagy to promote liver ischemia\/reperfusion injury by inhibiting \u03b2-catenin in mice. PLoS ONE, 15(11):e0239119. https:\/\/doi.org\/10.1371\/journal.pone.0239119","journal-title":"PLoS ONE"},{"issue":"2","key":"749_CR126","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3892\/or.2016.4864","volume":"36","author":"YH Yan","year":"2016","unstructured":"Yan YH, Liang ZH, Du Q, et al., 2016. MicroRNA-23a down-regulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells. Oncol Rep, 36(2): 633\u2013640. https:\/\/doi.org\/10.3892\/or.2016.4864","journal-title":"Oncol Rep"},{"issue":"9","key":"749_CR127","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00262-020-02586-9","volume":"69","author":"YH Yan","year":"2020","unstructured":"Yan YH, Zheng LT, Du Q, et al., 2020. Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells. Cancer Immunol Immunother, 69(9):1891\u20131903. https:\/\/doi.org\/10.1007\/s00262-020-02586-9","journal-title":"Cancer Immunol Immunother"},{"key":"749_CR128","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.canlet.2021.03.002","volume":"506","author":"YH Yan","year":"2021","unstructured":"Yan YH, Zheng LT, Du Q, et al., 2021a. Interferon regulatory factor 1 (IRF-1) activates anti-tumor immunity via CXCL10\/CXCR3 axis in hepatocellular carcinoma (HCC). Cancer Lett, 506:95\u2013106. https:\/\/doi.org\/10.1016\/j,canlet.2021.03.002","journal-title":"Cancer Lett"},{"issue":"1","key":"749_CR129","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41416-021-01337-6","volume":"125","author":"YH Yan","year":"2021","unstructured":"Yan YH, Zheng LT, Du Q, et al., 2021b. Interferon regulatory factor 1 (IRF-1) downregulates Checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in Hepatocellular carcinoma (HCC) cells. Br J Cancer, 125(1):101\u2013111. https:\/\/doi.org\/10.1038\/s41416-021-01337-6","journal-title":"Br J Cancer"},{"issue":"8","key":"749_CR130","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.4161\/onci.22475","volume":"1","author":"H Yanai","year":"2012","unstructured":"Yanai H, Negishi H, Taniguchi T, 2012. The IRF family of transcription factors: inception, impact and implications in on-cogenesis. Oncoimmunology, 1(8):1376\u20131386. https:\/\/doi.org\/10.4161\/onci.22475","journal-title":"Oncoimmunology"},{"issue":"3","key":"749_CR131","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/hep.29605","volume":"67","author":"MQ Yang","year":"2018","unstructured":"Yang MQ, Du Q, Goswami J, et al., 2018. Interferon regulatory factor 1-Rab27a regulated extracellular vesicles promote liver ischemia\/reperfusion injury. Hepatology, 67(3):1056\u20131070. https:\/\/doi.org\/10.1002\/hep.29605","journal-title":"Hepatology"},{"issue":"6","key":"749_CR132","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/hep.510290624","volume":"29","author":"H Yano","year":"1999","unstructured":"Yano H, Iemura A, Haramaki M, et al., 1999. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines. Hepatology, 29(6): 1708\u20131717. https:\/\/doi.org\/10.1002\/hep.510290624","journal-title":"Hepatology"},{"issue":"12","key":"749_CR133","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.4049\/jimmunol.1402505","volume":"194","author":"S Yokota","year":"2015","unstructured":"Yokota S, Yoshida O, Dou L, et al., 2015. IRF-1 promotes liver transplant ischemia\/reperfusion injury via hepatocyte IL-15\/IL-15Ra production. J Immunol, 194(12): 6045\u20136056. https:\/\/doi.org\/10.4049\/jimmunol.1402505","journal-title":"J Immunol"},{"issue":"3","key":"749_CR134","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3892\/ijo.2017.3852","volume":"50","author":"M Yu","year":"2017","unstructured":"Yu M, Xue HZ, Wang YD, et al., 2017. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR\/STAT3\/AKT pathway in hepatocellular carcinoma. Int J Oncol, 50(3):975\u2013983. https:\/\/doi.org\/10.3892\/ijo.2017.3852","journal-title":"Int J Oncol"},{"issue":"1","key":"749_CR135","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/imm.13611","volume":"169","author":"WW Yu","year":"2023","unstructured":"Yu WW, He JB, Wang F, et al., 2023. NR4A1 mediates NK-cell dysfunction in hepatocellular carcinoma via the IFN-\u03b3\/p-STAT1\/IRF1 pathway. Immunology, 169(1):69\u201382. https:\/\/doi.org\/10.1111\/imm.13611","journal-title":"Immunology"},{"issue":"4","key":"749_CR136","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/MEG.0b013e3283329d00","volume":"22","author":"ARN Zekri","year":"2010","unstructured":"Zekri ARN, Moharram RAN, Mohamed WS, et al., 2010. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1. Eur J Gastroenterol Hepatol, 22(4):450\u2013456. https:\/\/doi.org\/10.1097\/MEG.0b013e3283329d00","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"749_CR137","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/imcb.12185","volume":"96","author":"K Zenke","year":"2018","unstructured":"Zenke K, Muroi M, Tanamoto KI, 2018. IRF1 supports DNA binding of STAT1 by promoting its phosphorylation. Immunol Cell Biol, 96(10):1095\u20131103. https:\/\/doi.org\/10.1111\/imcb.12185","journal-title":"Immunol Cell Biol"},{"issue":"25","key":"749_CR138","doi-asserted-by":"publisher","first-page":"37979","DOI":"10.18632\/oncotarget.9365","volume":"7","author":"HM Zhang","year":"2016","unstructured":"Zhang HM, Li SP, Yu Y, et al., 2016. Bi-directional roles of IRF-1 on autophagy diminish its prognostic value as compared with Ki67 in liver transplantation for hepatocellular carcinoma. Oncotarget, 7(25):37979\u201337992. https:\/\/doi.org\/10.18632\/oncotarget.9365","journal-title":"Oncotarget"},{"issue":"4","key":"749_CR139","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1002\/jcp.29264","volume":"235","author":"L Zhang","year":"2020","unstructured":"Zhang L, Song YL, Chen L, et al., 2020. MiR-20a-containing exosomes from umbilical cord mesenchymal stem cells alleviates liver ischemia\/reperfusion injury. J Cell Physiol, 235(4):3698\u20133710. https:\/\/doi.org\/10.1002\/jcp.29264","journal-title":"J Cell Physiol"},{"issue":"4","key":"749_CR140","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12032-021-01638-z","volume":"39","author":"LM Zhang","year":"2022","unstructured":"Zhang LM, Cheng TL, Yang H, et al., 2022. Interferon regulatory factor-1 regulates cisplatin-induced apoptosis and autophagy in A549 lung cancer cells. Med Oncol, 39(4):38. https:\/\/doi.org\/10.1007\/s12032-021-01638-z","journal-title":"Med Oncol"},{"issue":"12","key":"749_CR141","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1080\/15548627.2020.1719681","volume":"16","author":"MQ Zhang","year":"2020","unstructured":"Zhang MQ, Zhao Q, Zhang JP, 2020. A new transcription factor ATG10S activates IFNL2 transcription by binding at an IRF1 site in HepG2 cells. Autophagy, 16(12):2167\u20132179. https:\/\/doi.org\/10.1080\/15548627.2020.1719681","journal-title":"Autophagy"},{"key":"749_CR142","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.freeradbiomed.2022.11.002","volume":"193","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang JJ, Feng DY, et al., 2022. IRF1\/ZNF350\/GPX4-mediated ferroptosis of renal tubular epithelial cells promote chronic renal allograft interstitial fibrosis. Free Radic Biol Med, 193:579\u2013594. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.11.002","journal-title":"Free Radic Biol Med"},{"key":"749_CR143","doi-asserted-by":"publisher","first-page":"5391058","DOI":"10.1155\/2020\/5391058","volume":"2020","author":"YC Zhang","year":"2020","unstructured":"Zhang YC, Zhang YL, Wang J, et al., 2020. Amarogentin inhibits liver cancer cell angiogenesis after insufficient ra-diofrequency ablation via affecting stemness and the p53-dependent VEGFA\/Dll4\/Notch1 pathway. Biomed Res Int, 2020:5391058. https:\/\/doi.org\/10.1155\/2020\/5391058","journal-title":"Biomed Res Int"},{"key":"749_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2022.01.004","volume":"64","author":"H Zhou","year":"2022","unstructured":"Zhou H, Tang YD, Zheng CF, 2022. Revisiting IRF1-mediated antiviral innate immunity. Cytokine Growth Factor Rev, 64:1\u20136. https:\/\/doi.org\/10.1016\/j.cytogfr.2022.01.004","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1\u20133","key":"749_CR145","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejphar.2006.03.013","volume":"537","author":"R Zhou","year":"2006","unstructured":"Zhou R, Tang W, Ren YX, et al., 2006. Preventive effects of (5R)-5-hydroxytriptolide on concanavalin A-induced hepatitis. Eur J Pharmacol, 537(1\u20133):181\u2013189. https:\/\/doi.org\/10.1016\/j.ejphar.2006.03.013","journal-title":"Eur J Pharmacol"},{"issue":"32","key":"749_CR146","doi-asserted-by":"publisher","first-page":"4715","DOI":"10.3748\/wjg.v25.i32.4715","volume":"25","author":"RX Zhu","year":"2019","unstructured":"Zhu RX, Cheng ASL, Chan HLY, et al., 2019. Growth arrest-specific gene 2 suppresses hepatocarcinogenesis by intervention of cell cycle and p53-dependent apoptosis. World J Gastroenterol, 25(32):4715\u20134726. https:\/\/doi.org\/10.3748\/wjg.v25.i32.4715","journal-title":"World J Gastroenterol"},{"issue":"1","key":"749_CR147","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.hbpd.2022.07.008","volume":"22","author":"SF Zhu","year":"2023","unstructured":"Zhu SF, Yuan W, Du YL, et al., 2023. Research progress of lncRNA and miRNA in hepatic ischemia-reperfusion injury. Hepatobiliary Pancreat Dis Int, 22(1):45\u201353. https:\/\/doi.org\/10.1016\/j.hbpd.2022.07.008","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"749_CR148","doi-asserted-by":"publisher","first-page":"110793","DOI":"10.1016\/j.cellsig.2023.110793","volume":"109","author":"HW Zuo","year":"2023","unstructured":"Zuo HW, Wang YX, Yuan MS, et al., 2023. Small extracellular vesicles from HO-1-modified bone marrow-derived mesenchymal stem cells attenuate ischemia-reperfusion injury after steatotic liver transplantation by suppressing ferroptosis via miR-214-3p. Cell Signal, 109:110793. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110793","journal-title":"Cell Signal"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2300159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2300159\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2300159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T06:02:01Z","timestamp":1720677721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2300159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":148,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2300159","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Tao CHEN, Shipeng LI, Dewen DENG, Weiye ZHANG, Jianjun ZHANG, and Zhongyang SHEN declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}